Cargando…
Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576036/ https://www.ncbi.nlm.nih.gov/pubmed/37833271 http://dx.doi.org/10.1038/s41408-023-00929-0 |
| _version_ | 1785121038563016704 |
|---|---|
| author | Sidana, Surbhi Hosoya, Hitomi Jensen, Alexandria Liu, Lawrence Goyal, Anmol Hovanky, Vanna Sahaf, Bita Bharadwaj, Sushma Latchford, Theresa Arai, Sally Leahy, Sheryl Mei, Matthew Budde, Lihua E. Muffly, Lori S. Frank, Matthew J. Dahiya, Saurabh Htut, Myo Miklos, David Janakiram, Murali |
| author_facet | Sidana, Surbhi Hosoya, Hitomi Jensen, Alexandria Liu, Lawrence Goyal, Anmol Hovanky, Vanna Sahaf, Bita Bharadwaj, Sushma Latchford, Theresa Arai, Sally Leahy, Sheryl Mei, Matthew Budde, Lihua E. Muffly, Lori S. Frank, Matthew J. Dahiya, Saurabh Htut, Myo Miklos, David Janakiram, Murali |
| author_sort | Sidana, Surbhi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10576036 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105760362023-10-15 Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma Sidana, Surbhi Hosoya, Hitomi Jensen, Alexandria Liu, Lawrence Goyal, Anmol Hovanky, Vanna Sahaf, Bita Bharadwaj, Sushma Latchford, Theresa Arai, Sally Leahy, Sheryl Mei, Matthew Budde, Lihua E. Muffly, Lori S. Frank, Matthew J. Dahiya, Saurabh Htut, Myo Miklos, David Janakiram, Murali Blood Cancer J Correspondence Nature Publishing Group UK 2023-10-13 /pmc/articles/PMC10576036/ /pubmed/37833271 http://dx.doi.org/10.1038/s41408-023-00929-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Sidana, Surbhi Hosoya, Hitomi Jensen, Alexandria Liu, Lawrence Goyal, Anmol Hovanky, Vanna Sahaf, Bita Bharadwaj, Sushma Latchford, Theresa Arai, Sally Leahy, Sheryl Mei, Matthew Budde, Lihua E. Muffly, Lori S. Frank, Matthew J. Dahiya, Saurabh Htut, Myo Miklos, David Janakiram, Murali Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma |
| title | Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma |
| title_full | Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma |
| title_fullStr | Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma |
| title_full_unstemmed | Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma |
| title_short | Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma |
| title_sort | bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to bcma car-t cell therapy in multiple myeloma |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576036/ https://www.ncbi.nlm.nih.gov/pubmed/37833271 http://dx.doi.org/10.1038/s41408-023-00929-0 |
| work_keys_str_mv | AT sidanasurbhi bendamustinevsfludarabinecyclophosphamidelymphodepletionpriortobcmacartcelltherapyinmultiplemyeloma AT hosoyahitomi bendamustinevsfludarabinecyclophosphamidelymphodepletionpriortobcmacartcelltherapyinmultiplemyeloma AT jensenalexandria bendamustinevsfludarabinecyclophosphamidelymphodepletionpriortobcmacartcelltherapyinmultiplemyeloma AT liulawrence bendamustinevsfludarabinecyclophosphamidelymphodepletionpriortobcmacartcelltherapyinmultiplemyeloma AT goyalanmol bendamustinevsfludarabinecyclophosphamidelymphodepletionpriortobcmacartcelltherapyinmultiplemyeloma AT hovankyvanna bendamustinevsfludarabinecyclophosphamidelymphodepletionpriortobcmacartcelltherapyinmultiplemyeloma AT sahafbita bendamustinevsfludarabinecyclophosphamidelymphodepletionpriortobcmacartcelltherapyinmultiplemyeloma AT bharadwajsushma bendamustinevsfludarabinecyclophosphamidelymphodepletionpriortobcmacartcelltherapyinmultiplemyeloma AT latchfordtheresa bendamustinevsfludarabinecyclophosphamidelymphodepletionpriortobcmacartcelltherapyinmultiplemyeloma AT araisally bendamustinevsfludarabinecyclophosphamidelymphodepletionpriortobcmacartcelltherapyinmultiplemyeloma AT leahysheryl bendamustinevsfludarabinecyclophosphamidelymphodepletionpriortobcmacartcelltherapyinmultiplemyeloma AT meimatthew bendamustinevsfludarabinecyclophosphamidelymphodepletionpriortobcmacartcelltherapyinmultiplemyeloma AT buddelihuae bendamustinevsfludarabinecyclophosphamidelymphodepletionpriortobcmacartcelltherapyinmultiplemyeloma AT mufflyloris bendamustinevsfludarabinecyclophosphamidelymphodepletionpriortobcmacartcelltherapyinmultiplemyeloma AT frankmatthewj bendamustinevsfludarabinecyclophosphamidelymphodepletionpriortobcmacartcelltherapyinmultiplemyeloma AT dahiyasaurabh bendamustinevsfludarabinecyclophosphamidelymphodepletionpriortobcmacartcelltherapyinmultiplemyeloma AT htutmyo bendamustinevsfludarabinecyclophosphamidelymphodepletionpriortobcmacartcelltherapyinmultiplemyeloma AT miklosdavid bendamustinevsfludarabinecyclophosphamidelymphodepletionpriortobcmacartcelltherapyinmultiplemyeloma AT janakirammurali bendamustinevsfludarabinecyclophosphamidelymphodepletionpriortobcmacartcelltherapyinmultiplemyeloma |